There are some huge questions around the vaccine development programme for Covid-19. When will one be ready? Will it be safe? How long will immunity last? Does it matter which one it is? SPOILER – Yes.
With the insight of Professor of Immunology Danny Altmann from Imperial College London, I delve into the subject and try to answer just about every question you might want to ask.
0:26 What is a vaccine and how do they work?
1:47 Why do we need a vaccine for Covid-19?
3:34 What are the different types of vaccine?
7:59 What are the most common misconceptions about a vaccine?
9:13 What does a good vaccine look like?
12:48 Who are the leading contenders?
13:43 How does the clinical trials process work?
16:28 What are the risks of rushing a vaccine?
19:14 And what about those waning antibodies?
21:42 How long can we expect a vaccine to last?
22:13 When will a vaccine be ready?
23:58 What about viral mutation?
25:26 Will it be safe?
27:14 If it’s legit, should you take it?
29:21 Conclusion
REFERENCES
RNA vaccine information
Recombinant Vector Vaccine information
BMJ – Sputnik
Dr Eric Topol – leading candidates:
ADE, or Antibody Dependent Enhancement
TH2 Lung pathology,
FDA under approvals pressure, The Guardian
Waning Antibodies
Dr Eric Topol – slow genetic drift
Vaccine Refuseniks
Oxford/AZ trial hold
Oxford/AZ trial restart
